Dr Reddy's Launches Generic Anti-Bacterial Drug in US
Dr Reddy's Laboratories has launched a generic Doxycycline Capsules (40 mg) in the US market, a therapeutic equivalent of Oracea capsules (40 mg).
New Delhi, May 3 (PTI) Dr Reddy's Laboratories on Friday said it has launched a generic medication, used to treat a wide variety of bacterial infections, in the US market.
The company has launched Doxycycline Capsules (40 mg) in the US market, the Hyderabad-based drug maker said in a statement.
The company's product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration (USFDA).
Shares of the company on Friday ended 0.71 per cent up at Rs 6,332.85 apiece on the BSE.
The company has launched Doxycycline Capsules (40 mg) in the US market, the Hyderabad-based drug maker said in a statement.
The company's product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration (USFDA).
Shares of the company on Friday ended 0.71 per cent up at Rs 6,332.85 apiece on the BSE.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.62 (+ 4.96)
- 103031030
- GTL Infrastructure
- 1.53 (+ 1.32)
- 21582832
- Guj. Toolroom Lt
- 1.72 (+ 3.61)
- 13450663
- Jaiprakash Power Ven
- 14.97 (+ 2.18)
- 13128177
- Standard Capital
- 0.56 ( -1.75)
- 13006780
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback